Printer Friendly

Browse Gemcitabine topic

Dosage and administration subtopic


1-20 out of 20 article(s)
Title Author Type Date Words
Taris Presents Preclinical Data on Effects of Low-Dose Bladder Delivery of Gemcitabine at AACR Annual Meeting. Apr 19, 2018 277
Aerosol Gemcitabine after Amputation Inhibits Osteosarcoma Lung Metastases but Not Wound Healing. Kleinerman, Eugenie S.; Yu, Ling; Dao, Jasmine; Hayes-Jordan, Andrea A.; Lindsey, Brock; Kawedia, Ji Report Jan 1, 2018 6043
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy. Choy, Edwin; Ballman, Karla; Chen, James; Dickson, Mark A.; Chugh, Rashmi; George, Suzanne; Okuno, S Report Jan 1, 2018 5838
A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy. Kasahara, Ryo; Kawahara, Takashi; Ohtake, Shinji; Saitoh, Yoko; Tsutsumi, Sohgo; Teranishi, Jun-ichi Report Jan 1, 2017 2574
Coadministration of a Gloriosa superba extract improves the in vivo antitumoural activity of gemcitabine in a murine pancreatic tumour model. Capistrano, Rica I.; Vangestel, Christel; Vanpachtenbeke, Hanne; Fransen, Erik; Staelens, Steven; Ap Report Nov 15, 2016 4620
Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2 pancreatic cell lines. Park, S.H.; Sung, J.H.; Kim, E.J.; Chung, N. Report Feb 1, 2015 4110
Initial experience of intravesical gemcitabine for patients with high-risk superficial transitional cell carcinoma of the bladder following BCG failure. Allchorne, Paula; Lamb, Benjamin W.; Kinsella, Janette; Shamash, Jonathan; Green, James S.A. Report Mar 1, 2014 3504
First-line gemcitabine plus cisplatin in nonsmall cell lung cancer patients. Li, Ying; Wang, Lin Run; Chen, Jian; Lou, Yan; Zhang, Guo Bing Report Jan 1, 2014 4137
Development and characterization of nanoparticles for the delivery of gemcitabine hydrochloride. Khaira, Rekha; Sharma, Jyoti; Saini, Vinay Report Jan 1, 2014 4115
Options and limitations of ductal pancreatic cancer treatment. Seufferlein, Thomas Report Oct 15, 2011 406
NCCAM/NCI phase 1 study of mistletoe extract and Gemcitabine in patients with advanced solid tumors. Mansky, P.J.; Wallerstedt, D.B.; Sannes, T.; Stagl, J.; Johnson, L.L.; Blackman, M.R.; Grem, J.L.; S Report Oct 15, 2011 446
FDA approves APP Pharmaceuticals' Gemcitabine HCI for Injection. May 19, 2011 134
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. Guillen, Ponce; Carrato, Alfredo Clinical report Oct 1, 2009 1431
In patients with unresectable (inoperable) pancreatic cancer, the combination of gemcitabine and a novel cationic liposomal formulation of paclitaxel called EndoTAG-1 substantially prolongs survival compared to gemcitabine therapy alone, according to a study presented last week. Brief article Jun 29, 2009 271
A Phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. Carrato, Alfredo; Guillen-Ponce, Carmen Dec 1, 2008 866
Gemcitabine and cisplatin in patients with locally advanced, recurrent, or metastatic head and neck cancer: results of a Phase II trial. Kyasa, Mouhammed J.; Breau, Randall L.; Hanna, Ehab; Suen, James; Maddox, Anne-Marie Mar 1, 2008 2464
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. Carrato, Alfredo; Guillen-Ponce, Carmen Clinical report Dec 1, 2007 1188
Bevacizumab disappoints in pancreatic cancer. Apr 1, 2007 437
Gemcitabine-radiation Tx thwarts pancreatic Ca. Wendling, Patrice Aug 1, 2005 572
Chemo boosts pancreatic cancer-free survival. MacNeil, Jane Salodof Aug 1, 2005 1073

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters